AustraliaDaily Briefs

Daily Brief Australia: Mma Offshore, Capitol Health, Tamboran Resources and more

In today’s briefing:

  • MMA Offshore (MRM AU): Disappointing Final Offer Poses a Vote Risk
  • Capitol Health (CAJ AU)/Integral Diagnostics (IDX AU): An Improved Image
  • Tamboran Resources US Offering – Strong Recent Momentum but CDIs Have Been Volatile Since Listing


MMA Offshore (MRM AU): Disappointing Final Offer Poses a Vote Risk

By Arun George

  • Cyan Renewables has bumped its Mma Offshore (MRM AU) offer to A$2.70 per share, a 3.8% premium to the previous A$2.60 offer.
  • The bump is derisory in the context of recent earnings upgrades. Since the binding proposal, MMA has upgraded its FY24 EBITDA and EBIT guidance by 9.8% and 15.5%, respectively.
  • The AFR reported that around 30% of the register opposed the previous offer. A cursory 3.8% bump is unlikely to sway most of these dissenters to change their views.

Capitol Health (CAJ AU)/Integral Diagnostics (IDX AU): An Improved Image

By David Blennerhassett

  • Diagnostic imaging provider Capitol Health (CAJ AU) has announced it has entered into a process deed with Integral Diagnostics (IDX AU)
  • This non-binding indicative Offer, by way of a Scheme, involves 0.12849 new IDX shares for each share of Capitol.  The next step is four weeks of two-way confirmatory due diligence.
  • The implied Offer Price under the scrip terms is A$0.3284/share. Should the transaction complete, Integral would hold 63% in the combined group. This is the second Integral/Capitol merger attempt.

Tamboran Resources US Offering – Strong Recent Momentum but CDIs Have Been Volatile Since Listing

By Clarence Chu

  • Tamboran Resources (TBN AU) is looking to raise US$175m from listing its shares in the US.
  • Tamboran Resources is an early stage, independent natural gas exploration and production company.
  • In this note, we talk about the deal dynamics and the listing impact.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars